DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Toliprolol
Toliprolol
Customs Tariff - Schedule
(12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
Ovid MEDLINE(R)
Chromatographic Analysis of Pharmaceuticals Second Edition, Revised and Expanded
Pharmaceuticals
Selective Reaction Monitoring (SRM) Daten Von Mehr Als 900 Xenobiotika Für Aufbau Und Validierung Von LC-MS/MS Analysen
Sustained-Release Compositions Containing Cation Exchange Resins and Polycarboxylic Polymers
Pharmaceutical Appendix to the Tariff Schedule 2
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
Customs Tariff - Schedule
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
A Study on Beta Blockers - a Brief Review Tv
Stembook 2018.Pdf
Entwicklung Von Screeningverfahren Für Arzneistoffe Und Metaboliten Mittels LC-MS Und LC-MS/MS
(12) United States Patent (10) Patent No.: US 8,637,524 B2 Rao Et Al
Pharmacotherapy for Mild Hypertension (Review) – the Cochrane Collaboration
(12) Patent Application Publication (10) Pub. No.: US 2004/0058896 A1 Dietrich Et Al
QSAR & Combinatorial Science
Top View
Index Vol. 16-23
Bindex 877..922
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Marrakesh Agreement Establishing the World Trade Organization
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Customs Tariff - Schedule
Manidipine Hydrochloride Maprotiline
Transdermal Device Containing
Customs Tariff - Schedule Xxi - 1
Progress in the Enantioseparation of -Blockers by Chromatographic Methods
Nitric Oxide Releasing Amino Acid Ester
Chromtech Chiral
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
6373542520814569898094647.Pdf
Asymmetric Synthesis Towards Bioactive
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
FROM QSAR to QNAR, DEVELOPING ENHANCED MODELS for DRUG DISCOVERY By
United States Patent (19) 11 Patent Number: 5,932,572 Dean Et Al
Harmonized Tariff Schedule of the United States (2006) (Rev
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
(19) United States (12) Patent Application Publication (10) Pub
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
Sustained-Release Compositions Containing Cation Exchange Resins and Polycarboxylic Polymers
Official Journal ISSN 0378-6978 L97 of the European Communities Volume 45
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
Ep 1472225 B1
Identification and Characterization of Antidiabetic And
University of Groningen PET Imaging of Beta-Adrenoceptors in Human Brain
E036128.Draft-Revisions.Pdf
Wo 2011/017108 A2